Glyco680mg - Management of glycemia
Glyco680mg is a combination of plant extracts and minerals formulated to target key drivers of normal glucose management. Glyco680mg is clinically proven to reduce postprandial glucose levels, contributing to overall metabolic homeostasis. Supported by an acute clinical study. 680 mg/day.
Glyco680mg - Key features
- Combines polyphenols with an α‑amylase inhibitor, chromium, and zinc
- Formulated to support glucose balance
- Helps maintain balanced glucose levels after meals
Science supporting Glyco680mg
An acute clinical study with the primary objective of evaluating the reduction in postprandial glucose levels was conducted following a randomised, single-blind, crossover design.
Certifications & Compliance
Non-GMO, gluten-free, suitable for vegetarians.
References
CLINICAL TRIALS
Publication pending, report available upon request
MECHANISTIC STUDIES
Publication pending, report available upon request
This website is intended to provide information about Biotexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public. Statements used on this website have not been evaluated by competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.
